Funds and ETFs Fortrea Holdings Inc.

Equities

FTRE

US34965K1079

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 12:12:49 2024-06-06 pm EDT 5-day change 1st Jan Change
27.14 USD -0.75% Intraday chart for Fortrea Holdings Inc. +12.06% -22.23%

ETFs positioned on Fortrea Holdings Inc.

Name Weight AuM 1st Jan change Investor Rating
0.05% 746 M€ -.--% -
0.00% 34 M€ +4.32% -
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
27.35 USD
Average target price
31.8 USD
Spread / Average Target
+16.27%
Consensus
  1. Stock Market
  2. Equities
  3. FTRE Stock
  4. Funds and ETFs Fortrea Holdings Inc.